IRADIMED CORPORATION (46K.F)
- Previous Close
45.40 - Open
51.00 - Bid 50.50 x --
- Ask 51.50 x --
- Day's Range
51.00 - 51.00 - 52 Week Range
38.80 - 61.00 - Volume
53 - Avg. Volume
7 - Market Cap (intraday)
739.316M - Beta (5Y Monthly) 0.92
- PE Ratio (TTM)
36.96 - EPS (TTM)
1.38 - Earnings Date Jul 31, 2025
- Forward Dividend & Yield 0.60 (1.33%)
- Ex-Dividend Date May 20, 2025
- 1y Target Est
--
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida.
www.iradimed.comRecent News: 46K.F
View MorePerformance Overview: 46K.F
Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 46K.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 46K.F
View MoreValuation Measures
Market Cap
658.13M
Enterprise Value
613.38M
Trailing P/E
32.90
Forward P/E
28.99
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.69
Price/Book (mrq)
7.20
Enterprise Value/Revenue
9.17
Enterprise Value/EBITDA
29.40
Financial Highlights
Profitability and Income Statement
Profit Margin
26.33%
Return on Assets (ttm)
14.92%
Return on Equity (ttm)
23.81%
Revenue (ttm)
75.15M
Net Income Avi to Common (ttm)
19.78M
Diluted EPS (ttm)
1.38
Balance Sheet and Cash Flow
Total Cash (mrq)
50.33M
Total Debt/Equity (mrq)
0.07%
Levered Free Cash Flow (ttm)
8.58M